ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 778 filers reported holding ASTRAZENECA PLC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,471 | -5.3% | 1,262 | +0.1% | 0.02% | +4.8% |
| Q2 2023 | $90,270 | -4.7% | 1,261 | -7.6% | 0.02% | -8.7% |
| Q1 2023 | $94,765 | +2.5% | 1,365 | +0.1% | 0.02% | 0.0% |
| Q4 2022 | $92,451 | +32.1% | 1,364 | +8.3% | 0.02% | +27.8% |
| Q3 2022 | $70,000 | -15.7% | 1,260 | +0.1% | 0.02% | -14.3% |
| Q2 2022 | $83,000 | +5.1% | 1,259 | +6.1% | 0.02% | +10.5% |
| Q1 2022 | $79,000 | +14.5% | 1,187 | +0.2% | 0.02% | +18.8% |
| Q4 2021 | $69,000 | -2.8% | 1,185 | 0.0% | 0.02% | -15.8% |
| Q3 2021 | $71,000 | +4.4% | 1,185 | +4.5% | 0.02% | 0.0% |
| Q2 2021 | $68,000 | +21.4% | 1,134 | 0.0% | 0.02% | +11.8% |
| Q1 2021 | $56,000 | -3.4% | 1,134 | -1.6% | 0.02% | -10.5% |
| Q4 2020 | $58,000 | -40.8% | 1,152 | -35.8% | 0.02% | -47.2% |
| Q3 2020 | $98,000 | -16.9% | 1,794 | -19.4% | 0.04% | -20.0% |
| Q2 2020 | $118,000 | +20.4% | 2,225 | +1.1% | 0.04% | +2.3% |
| Q1 2020 | $98,000 | -10.9% | 2,201 | 0.0% | 0.04% | -6.4% |
| Q4 2019 | $110,000 | – | 2,201 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |